✦ LIBER ✦

Influence of the BRAF V600E Mutation on Expression of Vascular Endothelial Growth Factor in Papillary Thyroid Cancer

✍ Scribed by Jo, Young Suk; Li, Shengjin; Song, Jung Hun; Kwon, Ki Hyun; Lee, Jun Chul; Rha, So Young; Lee, Hyo Jin; Sul, Ji Young; Kweon, Gi Ryang; Ro, Heung-kyu; Kim, Jin-Man; Shong, Minho

Book ID: 123615727
Publisher: Endocrine Society
Year: 2006
Tongue: English
Weight: 72 KB
Volume: 91
Category: Article
ISSN: 0021-972X
DOI: 10.1210/jc.2005-2836

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BRAF(V600E) mutation and the biology of

BRAF(V600E) mutation and the biology of papillary thyroid cancer

✍ Frasca, F; Nucera, C; Pellegriti, G; Gangemi, P; Attard, M; Stella, M; Loda, M; 📂 Article 📅 2008 🏛 Bioscientifica 🌐 English ⚖ 253 KB

Clinicopathologic significance of BRAF V

Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid : A meta-analysis

✍ Ju-Han Lee; Eung-Seok Lee; Young-Sik Kim 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 699 KB

## Abstract ## BACKGROUND. Numerous studies have investigated the clinical significance of __BRAF__ mutation in papillary thyroid carcinoma (PTC). However, there have been conflicting data on the usefulness of __BRAF__ mutation as a prognostic marker of PTC. To address this controversy, the freque

Clinical and therapeutic implications of

Clinical and therapeutic implications of Sprouty2 feedback dysregulation in BRAF V600E-mutation-positive papillary thyroid cancer

✍ Dultz, Linda A.; Dhar, Shumon; Ogilvie, Jennifer B.; Heller, Keith S.; Bar-Sagi, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 877 KB

Clinical utility of immunohistochemistry

Clinical utility of immunohistochemistry for the detection of the BRAF v600e mutation in papillary thyroid carcinoma

✍ Zagzag, Jonathan; Pollack, Aron; Dultz, Linda; Dhar, Shumon; Ogilvie, Jennifer B 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 598 KB

mRNA BRAF expression helps to identify p

mRNA BRAF expression helps to identify papillary thyroid carcinomas in thyroid nodules independently of the presence of BRAFV600E mutation

✍ Priscila Pereira Costa Araujo; Marjory Alana Marcello; Alfio Jose Tincani; Ana C 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 265 KB

The role of BRAF(V600E) mutation as poor

The role of BRAF(V600E) mutation as poor prognostic factor for the outcome of patients with intrathyroid papillary thyroid carcinoma

✍ Pelizzo, M.R.; Dobrinja, C.; Casal Ide, E.; Zane, M.; Lora, O.; Toniato, A.; Mia 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 284 KB